Peroxisomal bifunctional enzyme deficiency.

The Journal of clinical investigation (1989-03-01)
P A Watkins, W W Chen, C J Harris, G Hoefler, S Hoefler, D C Blake, A Balfe, R I Kelley, A B Moser, M E Beard
ABSTRACT

Peroxisomal function was evaluated in a male infant with clinical features of neonatal adrenoleukodystrophy. Very long chain fatty acid levels were elevated in both plasma and fibroblasts, and beta-oxidation of very long chain fatty acids in cultured fibroblasts was significantly impaired. Although the level of the bile acid intermediate trihydroxycoprostanoic acid was slightly elevated in plasma, phytanic acid and L-pipecolic acid levels were normal, as was plasmalogen synthesis in cultured fibroblasts. The latter three parameters distinguish this case from classical neonatal adrenoleukodystrophy. In addition, electron microscopy and catalase subcellular distribution studies revealed that, in contrast to neonatal adrenoleukodystrophy, peroxisomes were present in the patient's tissues. Immunoblot studies of peroxisomal beta-oxidation enzymes revealed that the bifunctional enzyme (enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase) was deficient in postmortem liver samples, whereas acyl-CoA oxidase and the mature form of beta-ketothiolase were present. Density gradient centrifugation of fibroblast homogenates confirmed that intact peroxisomes were present. Immunoblots of fibroblasts peroxisomal fractions showed that they contained acyl-CoA oxidase and beta-ketothiolase, but bifunctional enzyme was not detected. Northern analysis, however, revealed that mRNA coding for the bifunctional enzyme was present in the patient's fibroblasts. These results indicate that the primary biochemical defect in this patient is a deficiency of peroxisomal bifunctional enzyme. It is of interest that the phenotype of this patient resembled neonatal adrenoleukodystrophy and would not have been distinguished from this disorder by clinical study alone.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
L-Pipecolic acid, 99% (titration)
Sigma-Aldrich
Pipecolinic acid, 98%
Sigma-Aldrich
Phytanic acid, ≥96%, mixture of isomers
Sigma-Aldrich
Hexacosanoic acid, ≥95% (capillary GC)
Sigma-Aldrich
Pristanic acid solution, mixture of isomers, ethanol solution, ≥97% (GC)
Sigma-Aldrich
L-Pipecolic acid, Proline homolog., 99%
Sigma-Aldrich
Hexacosanoic acid, technical, ≥90% (GC)
Sigma-Aldrich
15(S)-Hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid, ~150 μg/mL in ethanol, ≥97.0% (HPLC)

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.